Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 101
Filtrar
Más filtros

Medicinas Complementárias
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Biol Res ; 56(1): 65, 2023 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-38041203

RESUMEN

BACKGROUND: Impaired pattern separation occurs in the early stage of Alzheimer's disease (AD), and hippocampal dentate gyrus (DG) neurogenesis participates in pattern separation. Here, we investigated whether spatial memory discrimination impairment can be improved by promoting the hippocampal DG granule cell neogenesis-mediated pattern separation in the early stage of AD by electroacupuncture (EA). METHODS: Five familial AD mutations (5 × FAD) mice received EA treatment at Baihui and Shenting points for 4 weeks. During EA, mice were intraperitoneally injected with BrdU (50 mg/kg) twice a day. rAAV containing Wnt5a shRNA was injected into the bilateral DG region, and the viral efficiency was evaluated by detecting Wnt5a mRNA levels. Cognitive behavior tests were conducted to assess the impact of EA treatment on cognitive function. The hippocampal DG area Aß deposition level was detected by immunohistochemistry after the intervention; The number of BrdU+/CaR+ cells and the gene expression level of calretinin (CaR) and prospero homeobox 1(Prox1) in the DG area of the hippocampus was detected to assess neurogenesis by immunofluorescence and western blotting after the intervention; The gene expression levels of FZD2, Wnt5a, DVL2, p-DVL2, CaMKII, and p-CaMKII in the Wnt signaling pathway were detected by Western blotting after the intervention. RESULTS: Cognitive behavioral tests showed that 5 × FAD mice had impaired pattern separation (P < 0.001), which could be improved by EA (P < 0.01). Immunofluorescence and Western blot showed that the expression of Wnt5a in the hippocampus was decreased (P < 0.001), and the neurogenesis in the DG was impaired (P < 0.001) in 5 × FAD mice. EA could increase the expression level of Wnt5a (P < 0.05) and promote the neurogenesis of immature granule cells (P < 0.05) and the development of neuronal dendritic spines (P < 0.05). Interference of Wnt5a expression aggravated the damage of neurogenesis (P < 0.05), weakened the memory discrimination ability (P < 0.05), and inhibited the beneficial effect of EA (P < 0.05) in AD mice. The expression level of Wnt pathway related proteins such as FZD2, DVL2, p-DVL2, CAMKII, p-CAMKII increased after EA, but the effect of EA was inhibited after Wnt5a was knocked down. In addition, EA could reduce the deposition of Aß plaques in the DG without any impact on Wnt5a. CONCLUSION: EA can promote hippocampal DG immature granule cell neogenesis-mediated pattern separation to improve spatial memory discrimination impairment by regulating Wnt5a in 5 × FAD mice.


Asunto(s)
Enfermedad de Alzheimer , Electroacupuntura , Ratones , Animales , Enfermedad de Alzheimer/terapia , Enfermedad de Alzheimer/metabolismo , Bromodesoxiuridina , Proteína Quinasa Tipo 2 Dependiente de Calcio Calmodulina/metabolismo , Hipocampo/metabolismo , Modelos Animales de Enfermedad , Neurogénesis , Giro Dentado/metabolismo
2.
Nutrients ; 13(8)2021 Aug 11.
Artículo en Inglés | MEDLINE | ID: mdl-34444918

RESUMEN

Mild cognitive impairment (MCI) designates the boundary area between cognitive function in natural aging and dementia, and this is viewed as a therapeutic window to prevent the occurrence of dementia. The current study investigated the neurocognitive effects of oral creatine (Cr) supplementation in young female Wistar rats that received intracerebroventricular injections of lipopolysaccharide (LPS) to mimic MCI. Neuromolecular changes within the dentate gyrus were analyzed following behavioral testing. We also investigated both neurocognitive and neuromolecular changes following Cr supplementation in the absence of LPS in young female Wistar rats to further investigate mechanisms. Interestingly, based on trial 2 of Barnes maze test, Cr supplementation ameliorated spatial learning and memory deficit induced by LPS, shown by decreased latency time and errors to reach the escape box (p < 0.0001, n = 12). Cr supplementation also attenuated recognition memory deficit induced by LPS, shown by increased amount of time taken to explore the new object (p = 0.002, n = 12) during novel object recognition testing. Within the dentate gyrus, Cr supplementation in LPS injected rats upregulated mTORC1 signaling (p = 0.026 for mTOR phosphorylation, p = 0.002 for p70S6K phosphorylation, n = 8) as well as the synapsin (p = 0.008) and PSD-95 synaptic proteins (p = 0.015), in comparisons to LPS injected rats. However, Cr supplementation failed to further enhance spatial memory and recognition memory in the absence of LPS. In conclusion, Cr ameliorates LPS-induced cognitive impairment in a rodent MCI model. Mechanistically, these phenotypic effects may, in part, be mitigated via an upregulation of mTORC1 signaling, and an enhancement in synaptogenesis in the dentate gyrus. While preliminary, these findings may inform future research investigating neurocognitive effects of Cr for MCI patients.


Asunto(s)
Disfunción Cognitiva/tratamiento farmacológico , Creatina/administración & dosificación , Giro Dentado/metabolismo , Suplementos Dietéticos , Trastornos de la Memoria/tratamiento farmacológico , Fenómenos Fisiológicos Nutricionales de los Animales/efectos de los fármacos , Animales , Conducta Animal/efectos de los fármacos , Disfunción Cognitiva/inducido químicamente , Modelos Animales de Enfermedad , Femenino , Lipopolisacáridos , Aprendizaje por Laberinto , Diana Mecanicista del Complejo 1 de la Rapamicina/metabolismo , Trastornos de la Memoria/inducido químicamente , Plasticidad Neuronal/efectos de los fármacos , Ratas , Ratas Wistar , Reconocimiento en Psicología/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Memoria Espacial/efectos de los fármacos , Regulación hacia Arriba/efectos de los fármacos
3.
J Chem Neuroanat ; 113: 101837, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-32534024

RESUMEN

Amyloid ß-peptides (Aß) are considered as a major hallmark of Alzheimer's disease (AD) that can induce synaptic loss and apoptosis in brain regions, particularly in the cortex and the hippocampus. Evidence suggests that crocin, as the major component of saffron, can exhibit neuromodulatory effects in AD. However, specific data related to their efficacy to attenuate the synaptic loss and neuronal death in animal models of AD are limited. Hence, we investigated the efficacy of crocin in the CA3 and dentate gyrus (DG) regions of the hippocampus and also in frontal cortex neurons employing a rat model of AD. Male Wistar rats were randomly divided into control, sham, AD model, crocin, and AD model + crocin groups, with 8 rats per group. AD model was established by injecting Aß1-42 into the frontal cortex rats, and thereafter the rats were administrated by crocin (30 mg/kg) for a duration of 12-day. The number of live cells, neuronal arborization and apoptosis were measured using a Cresyl violet, Golgi-Cox and TUNEL staining, respectively. Results showed that, the number of live cells in the hippocampus pyramidal neurons in the CA3 and granular cells in the DG regions of the AD rats significantly decreased, which was significantly rescued by crocin. Compared with the control group, the axonal, spine and dendrites arborization in the frontal cortex and CA3 region of the AD model group significantly decreased. The crocin could significantly reverse this arborization loss in the AD rats (P < 0.05). The apoptotic cell number in the CA3 and DG regions in the AD model group was significantly higher than that of the control group (P < 0.05), while crocin significantly decreased the apoptotic cell number in the AD group (P < 0.05). Conclusion. Crocin can improve the synaptic loss and neuronal death of the AD rats possibly by reducing the neuronal apoptosis.


Asunto(s)
Enfermedad de Alzheimer/patología , Región CA3 Hipocampal/efectos de los fármacos , Carotenoides/farmacología , Giro Dentado/efectos de los fármacos , Lóbulo Frontal/efectos de los fármacos , Células Piramidales/efectos de los fármacos , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Animales , Apoptosis/efectos de los fármacos , Región CA3 Hipocampal/metabolismo , Región CA3 Hipocampal/patología , Giro Dentado/metabolismo , Giro Dentado/patología , Modelos Animales de Enfermedad , Lóbulo Frontal/metabolismo , Lóbulo Frontal/patología , Masculino , Células Piramidales/metabolismo , Células Piramidales/patología , Ratas , Ratas Wistar
4.
Behav Brain Res ; 398: 112898, 2021 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-32905810

RESUMEN

The burden of depression is enormous, and numerous studies have found that major depressive disorder (MDD) induces cardiovascular disorders (CVD) and functional dyspepsia (FD). Excitingly, meranzin hydrate (MH), an absorbed bioactive compound of Aurantii Fructus Immaturus, reverses psychosocial stress-induced mood disorders, gastrointestinal dysfunction and cardiac disease. Pharmacological methods have repeatedly failed in antidepressant development over the past few decades, but repairing aberrant neural circuits might be a reasonable strategy. This article aimed to explore antidepressant-like effects and potential mechanisms of MH in a rat model of unpredictable chronic mild stress (UCMS). Utilizing blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI), we sought to find reliable neurocircuits or a dominant brain region revealing the multiple effects of MH. The results show that compared with UCMS rats, MH (10 mg/kg/day for 1 week i.g.)-treated rats exhibited decreased depression-like behaviour; increased expression of brain-derived neurotrophic factor (BDNF) in the hippocampal dentate gyrus; and normalized levels of adrenocorticotropic hormone (ACTH), corticosterone (CORT), and acylated ghrelin (AG). Additionally, the UCMS-induced rise in BOLD activation in the reward system was attenuated after MH treatment. A literature search shown that nucleus accumbens (NAc) and hypothalamus of the reward system might reveal multiple effects of MH on MDD-FD-CVD comorbidity. Further research will focus on the role of these two brain regions in treating depression associated with comorbidities.


Asunto(s)
Antidepresivos/farmacología , Cumarinas/farmacología , Giro Dentado/efectos de los fármacos , Depresión/tratamiento farmacológico , Medicamentos Herbarios Chinos , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Recompensa , Estrés Psicológico/tratamiento farmacológico , Animales , Antidepresivos/administración & dosificación , Conducta Animal/efectos de los fármacos , Factor Neurotrófico Derivado del Encéfalo/efectos de los fármacos , Cumarinas/administración & dosificación , Giro Dentado/metabolismo , Modelos Animales de Enfermedad , Sistema Hipotálamo-Hipofisario/metabolismo , Masculino , Ratas , Ratas Wistar
5.
Neuropharmacology ; 179: 108273, 2020 11 15.
Artículo en Inglés | MEDLINE | ID: mdl-32801025

RESUMEN

Functional ultrasound (fUS) is a new tool enabling the imaging of brain activity through the regional monitoring of cerebral blood volume (CBV) dynamics. This innovative technique has not yet demonstrated its full potential in pharmacological applications and drug development. In the current proof-of-concept study, the impact of atomoxetine (ATX), a potent norepinephrine reuptake inhibitor and non-stimulant treatment marketed in attention-deficit/hyperactivity-disorder, was evaluated in anesthetized rat using pharmacological functional ultrasound (pharmaco-fUS) at increasing doses (0.3, 1 and 3 mg/kg). Using regions of interest (acute changes of CBV and functional connectivity) or pixel-based (general linear modeling and independent component analysis) analysis, we here demonstrated that ATX consistently displayed a hemodynamic effect in the visual cortex, the dentate gyrus and thalamus, especially visual areas such as lateral posterior thalamic nuclei and lateral geniculate nuclei (LGN). The time profile of ATX effects was dose-dependent, with fastest CBV increases at the highest dose, and longer CBV increases at the intermediate dose. Standardizing the use of pharmaco-fUS could improve our understanding of the mechanism of action of drugs active in the brain and might constitute a new step to move forward in drug development for neurological disorders.


Asunto(s)
Inhibidores de Captación Adrenérgica/metabolismo , Clorhidrato de Atomoxetina/metabolismo , Giro Dentado/metabolismo , Tálamo/metabolismo , Ultrasonografía/métodos , Corteza Visual/metabolismo , Inhibidores de Captación Adrenérgica/farmacología , Animales , Clorhidrato de Atomoxetina/farmacología , Giro Dentado/diagnóstico por imagen , Giro Dentado/efectos de los fármacos , Masculino , Ratas , Ratas Endogámicas WKY , Tálamo/diagnóstico por imagen , Tálamo/efectos de los fármacos , Corteza Visual/diagnóstico por imagen , Corteza Visual/efectos de los fármacos
6.
Neuromolecular Med ; 22(3): 437-446, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32638207

RESUMEN

Major depressive disorder (MDD) is a leading cause of morbidity, and the fourth leading cause of disease burden worldwide. While MDD is a treatable condition for many individuals, others suffer from treatment-resistant depression (TRD). Here, we suggest the immunomodulatory compound AS101 as novel therapeutic alternative. We previously showed in animal models that AS101 reduces anxiety-like behavior and elevates levels of the brain-derived neurotrophic factor (BDNF), a protein that has a key role in the pathophysiology of depression. To explore the potential antidepressant properties of AS101, we used the extensively characterized chronic mild stress (CMS) model, and the depressive rat line (DRL Finally, in Exp. 3 to attain insight into the mechanism we knocked down BDNF in the hippocampus, and demonstrated that the beneficial effect of AS101 was abrogated. Together with the previously established safety profile of AS101 in humans, these results may represent the first step towards the development of a novel treatment option for MDD and TRD.


Asunto(s)
Antidepresivos/uso terapéutico , Factor Neurotrófico Derivado del Encéfalo/fisiología , Trastorno Depresivo/tratamiento farmacológico , Modelos Animales de Enfermedad , Etilenos/uso terapéutico , Hipocampo/efectos de los fármacos , Factores Inmunológicos/uso terapéutico , Animales , Antidepresivos/química , Factor Neurotrófico Derivado del Encéfalo/antagonistas & inhibidores , Giro Dentado/efectos de los fármacos , Giro Dentado/metabolismo , Trastorno Depresivo/etiología , Trastorno Depresivo/genética , Evaluación Preclínica de Medicamentos , Etilenos/química , Conducta Exploratoria/efectos de los fármacos , Técnicas de Silenciamiento del Gen , Hipocampo/metabolismo , Factores Inmunológicos/química , Masculino , Actividad Motora/efectos de los fármacos , Prueba de Campo Abierto , Interferencia de ARN , ARN Interferente Pequeño/genética , Ratas , Ratas Sprague-Dawley , Estrés Fisiológico , Sacarosa , Natación
7.
Aging (Albany NY) ; 12(13): 13824-13844, 2020 06 17.
Artículo en Inglés | MEDLINE | ID: mdl-32554862

RESUMEN

Vitamin D is an essential fat-soluble vitamin that participates in several homeostatic functions in mammalian organisms. Lower levels of vitamin D are produced in the older population, vitamin D deficiency being an accelerating factor for the progression of the aging process. In this review, we focus on the effect that vitamin D exerts in the aged brain paying special attention to the neurogenic process. Neurogenesis occurs in the adult brain in neurogenic regions, such as the dentate gyrus of the hippocampus (DG). This region generates new neurons that participate in cognitive tasks. The neurogenic rate in the DG is reduced in the aged brain because of a reduction in the number of neural stem cells (NSC). Homeostatic mechanisms controlled by the Wnt signaling pathway protect this pool of NSC from being depleted. We discuss in here the crosstalk between Wnt signaling and vitamin D, and hypothesize that hypovitaminosis might cause failure in the control of the neurogenic homeostatic mechanisms in the old brain leading to cognitive impairment. Understanding the relationship between vitamin D, neurogenesis and cognitive performance in the aged brain may facilitate prevention of cognitive decline and it can open a door into new therapeutic fields by perspectives in the elderly.


Asunto(s)
Envejecimiento/fisiología , Disfunción Cognitiva/epidemiología , Giro Dentado/crecimiento & desarrollo , Neurogénesis/fisiología , Deficiencia de Vitamina D/epidemiología , Vía de Señalización Wnt/fisiología , Animales , Disfunción Cognitiva/fisiopatología , Disfunción Cognitiva/prevención & control , Giro Dentado/citología , Giro Dentado/metabolismo , Giro Dentado/fisiopatología , Suplementos Dietéticos , Modelos Animales de Enfermedad , Humanos , Células-Madre Neurales/fisiología , Factores de Riesgo , Factores de Tiempo , Vitamina D/administración & dosificación , Vitamina D/metabolismo , Deficiencia de Vitamina D/dietoterapia , Deficiencia de Vitamina D/fisiopatología
8.
Psychoneuroendocrinology ; 106: 111-116, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-30974324

RESUMEN

Letrozole, a third-generation aromatase inhibitor, prevents the production of estrogens in the final step in conversion from androgens. Due to its efficacy at suppressing estrogens, letrozole has recently taken favor as a first-line adjuvant treatment for hormone-responsive breast cancer in middle-aged women. Though patient response to letrozole has generally been positive, there is conflicting evidence surrounding its effects on the development of depression. It is possible that the potential adverse effects of letrozole on mood are a result of the impact of hormonal fluctuations on neurogenesis in the hippocampus. Thus, to clarify the effects of letrozole on the hippocampus and behavior, we examined how chronic administration affects hippocampal neurogenesis and depressive-like behavior in middle-aged, intact female mice. Mice were given either letrozole (1 mg/kg) or vehicle by injection (i.p.) daily for 3 weeks. Depressive-like behavior was assessed during the last 3 days of treatment using the forced swim test, tail suspension test, and sucrose preference test. The production of new neurons was quantified using the immature neuronal marker doublecortin (DCX), and cell proliferation was quantified using the endogenous marker Ki67. We found that letrozole increased DCX and Ki67 expression and maturation in the dentate gyrus, but had no significant effect on depressive-like behavior. Our findings suggest that a reduction in estrogens in middle-aged females increases hippocampal neurogenesis without any adverse impact on depressive-like behavior; as such, this furthers our understanding of how estrogens modulate neurogenesis, and to the rationale for the utilization of letrozole in the clinical management of breast cancer.


Asunto(s)
Hipocampo/efectos de los fármacos , Letrozol/metabolismo , Neurogénesis/efectos de los fármacos , Animales , Aromatasa/metabolismo , Inhibidores de la Aromatasa/farmacología , Conducta Animal/efectos de los fármacos , Proliferación Celular , Giro Dentado/metabolismo , Depresión/tratamiento farmacológico , Proteínas de Dominio Doblecortina , Proteína Doblecortina , Estrógenos/metabolismo , Femenino , Hipocampo/metabolismo , Letrozol/farmacología , Ratones , Proteínas Asociadas a Microtúbulos/metabolismo , Células-Madre Neurales , Neuronas/metabolismo , Neuropéptidos/metabolismo
9.
Rejuvenation Res ; 22(2): 131-137, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30009679

RESUMEN

Kaixin-San (KXS), a Chinese formula, was used to treat "amnesia," a senile dementia in the modern world. This formula was reported to improve behavioral performances in many animal models. This study was designed to explore how KXS has improved amyloid-ß (Aß)-induced memory dysfunction in mice. The mouse models were achieved through unilateral ventricle injection with Aß42. The effects of KXS on memory improvement were evaluated by the step-down test. The electrophysiological changes induced by KXS were measured by long-term potentiation (LTP) analysis in the hippocampus in vivo. The expression of glutamate receptor 2 (GluR2) was observed through immunohistochemical staining. Behavioral experiment outcome demonstrated reduced avoidance time and increased error time during the step-down test in the mice of Aß group. This memory impairment, however, was reversed by KXS. Electrophysiological experiment showed no significant difference between Aß group and KXS group either in the size or the shape of field excitatory postsynaptic potentiation recorded from perforant path to dentate gyrus pathway. However, LTP in this region was reduced by Aß and recovered by KXS administration. Moreover, immunohistochemical staining showed increased postsynaptic GluR2 expression in DG area in KXS group. These findings suggest that Aß results in impairment to memory function of the animals, and KXS protects the animal from memory loss by rescuing LTP through postsynaptic mechanism which refers to increasing GluR2 expression.


Asunto(s)
Péptidos beta-Amiloides/toxicidad , Medicamentos Herbarios Chinos/uso terapéutico , Hipocampo/fisiopatología , Potenciación a Largo Plazo , Trastornos de la Memoria/tratamiento farmacológico , Trastornos de la Memoria/fisiopatología , Receptores AMPA/metabolismo , Sinapsis/metabolismo , Animales , Giro Dentado/efectos de los fármacos , Giro Dentado/metabolismo , Giro Dentado/fisiopatología , Medicamentos Herbarios Chinos/farmacología , Hipocampo/efectos de los fármacos , Potenciación a Largo Plazo/efectos de los fármacos , Ratones Endogámicos ICR
10.
Eur J Pharmacol ; 842: 231-238, 2019 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-30391741

RESUMEN

Benzodiazepine receptor agonists are widely prescribed therapeutic agents, alter gamma-aminobutyric acid (GABA)A receptor function, and have hypnotic, anxiolytic, anticonvulsant, and antispastic effects. GABAA receptor activity increases under systemic inflammatory conditions. We investigated the effect of benzodiazepine receptor agonists on pentobarbital-induced loss of righting reflex (LORR) duration using a mouse model of lipopolysaccharide (LPS)-induced inflammation. We assessed pentobarbital-induced LORR duration 24 h after LPS treatment in mice. Additionally, we examined the microglial response by immunohistochemistry and serum IL-6 and TNF-α concentrations in mice. LPS treatment significantly increased the duration of pentobarbital-induced LORR in mice treated with benzodiazepine receptor agonists (diazepam and brotizolam) and a GABAA receptor agonist (muscimol) compared to that of mice treated with vehicle. These effects were blocked by bicuculline, a GABAA receptor antagonist. LPS significantly increased the number of ionized calcium binding adapter molecule-1-positive hippocampal cells 2 and 24 h after treatment. The enhancing effect of diazepam in LPS-treated mice was significantly reduced by minocycline. These findings suggest that LPS enhances pentobarbital-induced LORR duration in mice treated with benzodiazepine via GABAA receptor activity.


Asunto(s)
Diazepam/farmacología , Lipopolisacáridos/farmacología , Pentobarbital/farmacología , Reflejo de Enderezamiento/efectos de los fármacos , Animales , Giro Dentado/efectos de los fármacos , Giro Dentado/metabolismo , Lóbulo Frontal/efectos de los fármacos , Lóbulo Frontal/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Interleucina-6/sangre , Interleucina-6/genética , Ratones , ARN Mensajero/genética , ARN Mensajero/metabolismo , Factores de Tiempo , Factor de Necrosis Tumoral alfa/sangre , Factor de Necrosis Tumoral alfa/genética
11.
Alcohol ; 76: 47-57, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30557779

RESUMEN

We have reported that moderate prenatal alcohol exposure (PAE) elevates histamine H3 receptor-mediated inhibition of glutamatergic neurotransmission in dentate gyrus (DG), and that the H3 receptor antagonist ABT-239 ameliorates PAE-induced deficits in DG long-term potentiation. Here, we investigated whether PAE alters other markers of histaminergic neurotransmission. Long-Evans rat dams voluntarily consumed either a 0% or a 5% ethanol solution 4 h each day throughout gestation. Young adult female offspring from each prenatal treatment group were used in histidine decarboxylase (HDC) immunohistochemical studies of histamine neuron number in ventral hypothalamus, quantitative Western blotting studies of HDC expression in multiple brain regions, radiohistochemical studies of H2 receptor density in multiple brain regions, and in biochemical studies of H2 receptor-effector coupling in dentate gyrus. Rat dams consumed a mean of 1.90 g of ethanol/kg/day during pregnancy. This level of consumption did not affect maternal weight gain, offspring birth weight, or litter size. PAE did not affect the number of HDC-positive neurons in ventral hypothalamus. However, HDC expression was reduced in frontal cortex, dentate gyrus, and cerebellum of PAE rats compared to controls. Specific [125I]-iodoaminopotentidine binding to H2 receptors was not altered in any of the brain regions measured, nor was basal or H2 receptor agonist-stimulated cAMP accumulation in DG altered in PAE rats compared to controls. These results suggest that not all markers of histaminergic neurotransmission are altered by PAE. However, the observation that HDC levels were reduced in the same brain regions where elevated H3 receptor-effector coupling was observed previously raises the question of whether a cause-effect relationship exists between HDC expression and H3 receptor function in affected brain regions of PAE rats. This relationship, along with the question of why these effects occur in some, but not all brain regions, requires more-detailed investigation.


Asunto(s)
Cerebelo/metabolismo , Giro Dentado/metabolismo , Lóbulo Frontal/metabolismo , Histamina/metabolismo , Histidina Descarboxilasa/biosíntesis , Efectos Tardíos de la Exposición Prenatal/metabolismo , Receptores Histamínicos H2/metabolismo , Animales , Recuento de Células , Femenino , Hipotálamo/efectos de los fármacos , Masculino , Neuronas/efectos de los fármacos , Embarazo , Ensayo de Unión Radioligante , Ratas
12.
Biol Pharm Bull ; 41(10): 1593-1599, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30270329

RESUMEN

Yokukansan (YKS) is a traditional Japanese herbal medicine. It has been currently applied for treating behavioral and psychological symptoms of dementia in Japan. We investigated the effect of YKS on learning ability, hippocampal cell proliferation, and neural ultrastructural features in senescence-accelerated mouse prone 8 (SAMP8), a proposed animal model of Alzheimer's disease. Five-month-old male SAMP8 mice were randomly assigned to control and experimental groups. The control group had drug-free water ad libitum. The experimental mice were given 0.15% aqueous solution of YKS orally for eight weeks. Learning ability was assessed in Morris water maze test. Hippocampal cell proliferation was investigated using bromodeoxyuridine immunohistochemical method. The neural ultrastructural features, including myelin sheath and synapse, were investigated electron microscopy. Administration with YKS improved the hippocampal cell proliferation in dentate gyrus, and ameliorated learning impairment in SAMP8 mice. Numerous lipofuscin inclusions were presented in hippocampal neurons of the control mice. However, little were found after treatment with YKS. Myelin sheath was thicker and postsynaptic density length was longer after treatment with YKS. Administration with YKS ameliorated learning impairment in SAMP8 mice, mediated at least partially via delaying neuronal aging process, neurogenesis, myelin sheath and synaptic plasticity in the hippocampus. These results suggest that YKS might be effective for preventing hippocampus-dependent cognitive deficits with age.


Asunto(s)
Enfermedad de Alzheimer , Trastornos del Conocimiento/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Hipocampo/efectos de los fármacos , Aprendizaje por Laberinto/efectos de los fármacos , Neurogénesis/efectos de los fármacos , Fitoterapia , Envejecimiento , Enfermedad de Alzheimer/complicaciones , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/metabolismo , Animales , Trastornos del Conocimiento/metabolismo , Giro Dentado/efectos de los fármacos , Giro Dentado/metabolismo , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/farmacología , Hipocampo/metabolismo , Lipofuscina/metabolismo , Masculino , Ratones , Vaina de Mielina/efectos de los fármacos , Plasticidad Neuronal/efectos de los fármacos , Distribución Aleatoria , Sinapsis/efectos de los fármacos
13.
Mol Neurobiol ; 55(10): 7677-7690, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29435917

RESUMEN

It is widely accepted that the synaptic dysfunction and synapse loss contribute to the cognitive deficits of vascular dementia (VD) patients. We have previously reported that acupuncture improved cognitive function in rats with VD. However, the mechanisms involved in acupuncture improving cognitive ability remain to be elucidated. The present study aims to investigate the pathways and molecules involved in the neuroprotective effect of acupuncture. We assessed the effects of acupuncture on hippocampal long-term potentiation (LTP), the most prominent cellular model of memory formation. Acupuncture enhanced LTP and norepinephrine (NE) levels in the hippocampus. Inhibition of the ß-adrenergic receptor (AR), but not the α-AR, was able to block the effects of acupuncture on hippocampal LTP. Furthermore, inhibition of ß1-AR, not ß2-AR, abolished the enhanced LTP induced by acupuncture. The expression analysis revealed a significant upregulation of ß1-AR and unchanged ß2-AR with acupuncture, which supported the above findings. Specifically, increased ß1-ARs in the dentate gyrus were expressed on neurons exclusively. Taken together, the present data supports a beneficial role of acupuncture in synaptic plasticity challenged with VD. A likely mechanism is the increase of NE and activation of ß1-AR in the hippocampus.


Asunto(s)
Terapia por Acupuntura , Demencia Vascular/fisiopatología , Demencia Vascular/terapia , Hipocampo/patología , Hipocampo/fisiopatología , Potenciación a Largo Plazo , Receptores Adrenérgicos beta/metabolismo , Animales , Giro Dentado/metabolismo , Masculino , Norepinefrina/metabolismo , Ratas Wistar , Receptores Adrenérgicos alfa/metabolismo
14.
Mol Psychiatry ; 23(4): 1031-1039, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-28485407

RESUMEN

In the adult mammalian brain, newborn granule cells are continuously integrated into hippocampal circuits, and the fine-tuning of this process is important for hippocampal function. Thus, the identification of factors that control adult neural stem cells (NSCs) maintenance, differentiation and integration is essential. Here we show that the deletion of the iron trafficking protein lipocalin-2 (LCN2) induces deficits in NSCs proliferation and commitment, with impact on the hippocampal-dependent contextual fear discriminative task. Mice deficient in LCN2 present an increase in the NSCs population, as a consequence of a G0/G1 cell cycle arrest induced by increased endogenous oxidative stress. Of notice, supplementation with the iron-chelating agent deferoxamine rescues NSCs oxidative stress, promotes cell cycle progression and improves contextual fear conditioning. LCN2 is, therefore, a novel key modulator of neurogenesis that, through iron, controls NSCs cell cycle progression and death, self-renewal, proliferation and differentiation and, ultimately, hippocampal function.


Asunto(s)
Discriminación en Psicología/fisiología , Lipocalina 2/metabolismo , Neurogénesis/fisiología , Animales , Diferenciación Celular/fisiología , Movimiento Celular/fisiología , Proliferación Celular/fisiología , Giro Dentado/metabolismo , Miedo/fisiología , Hipocampo/citología , Hipocampo/metabolismo , Lipocalina 2/genética , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Células-Madre Neurales/citología , Células-Madre Neurales/metabolismo , Células-Madre Neurales/fisiología , Neurogénesis/genética , Neuronas/citología , Neuronas/metabolismo
15.
Sci Rep ; 7(1): 9077, 2017 08 22.
Artículo en Inglés | MEDLINE | ID: mdl-28831054

RESUMEN

The muscarinic receptor response to acetylcholine regulates the hippocampal-related learning, memory, neural plasticity and the production and processing of the pro-nerve growth factor (proNGF) by hippocampal cells. The development and progression of diabetes generate a mild cognitive impairment reducing the functions of the septo-hippocampal cholinergic circuitry, depressing neural plasticity and inducing proNGF accumulation in the brain. Here we demonstrate, in a rat model of early type-1 diabetes, that a physical therapy, the electroacupuncture, counteracts the diabetes-induced deleterious effects on hippocampal physiology by ameliorating hippocampal-related memory functions; recovering the impaired long-term potentiation at the dentate gyrus (DG-LTP) and the lowered expression of the vesicular glutamate transporter 1; normalizing the activity-dependent release of proNGF in diabetic rat hippocampus. Electroacupuncture exerted its therapeutic effects by regulating the expression and activity of M1- and M2-acetylcholine muscarinic receptors subtypes in the dentate gyrus of hippocampus. Our results suggest that a physical therapy based on repetitive sensory stimulation could promote hippocampal neural activity, neuronal metabolism and functions, and conceivably improve the diabetes-induced cognitive impairment. Our data can support the setup of therapeutic protocols based on a better integration between physical therapies and pharmacology for the cure of diabetes-associated neurodegeneration and possibly for Alzheimer's disease.


Asunto(s)
Electroacupuntura , Hipocampo/metabolismo , Hipocampo/fisiopatología , Muscarina/metabolismo , Animales , Recuento de Células , Giro Dentado/metabolismo , Giro Dentado/fisiopatología , Diabetes Mellitus Experimental , Potenciación a Largo Plazo , Memoria , Modelos Biológicos , Factores de Crecimiento Nervioso/genética , Factores de Crecimiento Nervioso/metabolismo , Plasticidad Neuronal , Precursores de Proteínas/genética , Precursores de Proteínas/metabolismo , Células Piramidales/metabolismo , Células Piramidales/patología , Ratas , Receptor Muscarínico M1/metabolismo , Receptor Muscarínico M2/metabolismo , Receptores Muscarínicos/metabolismo
16.
Mol Cell Neurosci ; 82: 126-136, 2017 07.
Artículo en Inglés | MEDLINE | ID: mdl-28506637

RESUMEN

Thiamine is essential for normal brain function and its deficiency causes metabolic impairment, specific lesions, oxidative damage and reduced adult hippocampal neurogenesis (AHN). Thiamine precursors with increased bioavailability, especially benfotiamine, exert neuroprotective effects not only for thiamine deficiency (TD), but also in mouse models of neurodegeneration. As it is known that AHN is impaired by stress in rodents, we exposed C57BL6/J mice to predator stress for 5 consecutive nights and studied the proliferation (number of Ki67-positive cells) and survival (number of BrdU-positive cells) of newborn immature neurons in the subgranular zone of the dentate gyrus. In stressed mice, the number of Ki67- and BrdU-positive cells was reduced compared to non-stressed animals. This reduction was prevented when the mice were treated (200mg/kg/day in drinking water for 20days) with thiamine or benfotiamine, that were recently found to prevent stress-induced behavioral changes and glycogen synthase kinase-3ß (GSK-3ß) upregulation in the CNS. Moreover, we show that thiamine and benfotiamine counteract stress-induced bodyweight loss and suppress stress-induced anxiety-like behavior. Both treatments induced a modest increase in the brain content of free thiamine while the level of thiamine diphosphate (ThDP) remained unchanged, suggesting that the beneficial effects observed are not linked to the role of this coenzyme in energy metabolism. Predator stress increased hippocampal protein carbonylation, an indicator of oxidative stress. This effect was antagonized by both thiamine and benfotiamine. Moreover, using cultured mouse neuroblastoma cells, we show that in particular benfotiamine protects against paraquat-induced oxidative stress. We therefore hypothesize that thiamine compounds may act by boosting anti-oxidant cellular defenses, by a mechanism that still remains to be unveiled. Our study demonstrates, for the first time, that thiamine and benfotiamine prevent stress-induced inhibition of hippocampal neurogenesis and accompanying physiological changes. The present data suggest that thiamine precursors with high bioavailability might be useful as a complementary therapy in several neuropsychiatric disorders.


Asunto(s)
Hipocampo/efectos de los fármacos , Neurogénesis/efectos de los fármacos , Tiamina Pirofosfato/farmacología , Tiamina/análogos & derivados , Tiamina/metabolismo , Animales , Giro Dentado/efectos de los fármacos , Giro Dentado/metabolismo , Modelos Animales de Enfermedad , Glucógeno Sintasa Quinasa 3/efectos de los fármacos , Glucógeno Sintasa Quinasa 3/metabolismo , Hipocampo/metabolismo , Masculino , Ratones Endogámicos C57BL , Tiamina/farmacología
17.
Stroke ; 48(4): 1044-1051, 2017 04.
Artículo en Inglés | MEDLINE | ID: mdl-28289242

RESUMEN

BACKGROUND AND PURPOSE: Emerging evidence suggests that acupuncture could improve cognitive impairment in vascular dementia by enhancing synaptic plasticity in the hippocampus. The purpose of this study is to investigate whether dopamine, a key mediator of synaptic plasticity, is involved in this cognitive improvement. METHODS: Vascular dementia model was established by bilateral common carotid arteries occlusion in male Wistar rats. Three days after the operation, animals received acupuncture treatment for 2 weeks, once daily. The D1/D5 receptors antagonist SCH23390 was administered intraperitoneally 15 minutes before each acupuncture treatment. Morris water maze was examined after acupuncture. Long-term potentiation was studied by an electrophysiological technique. Dopamine and metabolites levels were detected by microdialysis and high-performance liquid chromatography from brain tissue. The expression of D1R and D5R was analyzed by immunofluorescence. RESULTS: Acupuncture remarkably reversed cognitive deficits in 2-vessel occlusion model (2VO) rats, and the acupuncture points Zusanli (ST36) and Baihui (GV20) were confirmed to be the most effective combination. Electrophysiological recording data showed that 2VO-induced impairments of long-term potentiation were prevented by acupuncture. In addition, acupuncture promoted the release of dopamine and its major metabolites in the hippocampus of 2VO rats. The immunofluorescence experiment showed that the decrease of D1R and D5R in hippocampal dentate gyrus region of 2VO rats was reversed by acupuncture. Furthermore, we found that the effects of acupuncture against 2VO-induced impairments in cognition and synaptic plasticity were abolished by SCH23390. CONCLUSIONS: Improvement in cognition and hippocampal synaptic plasticity induced by acupuncture was achieved via activation of D1/D5 receptors in 2VO rats.


Asunto(s)
Terapia por Acupuntura/métodos , Demencia Vascular/terapia , Giro Dentado/metabolismo , Giro Dentado/fisiopatología , Antagonistas de Dopamina/farmacología , Potenciación a Largo Plazo/fisiología , Trastornos de la Memoria/terapia , Receptores de Dopamina D1/metabolismo , Receptores de Dopamina D5/metabolismo , Animales , Conducta Animal , Benzazepinas/administración & dosificación , Benzazepinas/farmacología , Demencia Vascular/complicaciones , Modelos Animales de Enfermedad , Antagonistas de Dopamina/administración & dosificación , Masculino , Trastornos de la Memoria/etiología , Ratas , Ratas Wistar
18.
Sci Rep ; 7: 40726, 2017 01 18.
Artículo en Inglés | MEDLINE | ID: mdl-28098178

RESUMEN

Lithium (Li) is a potent mood stabilizer and displays neuroprotective and neurogenic properties. Despite extensive investigations, the mechanisms of action have not been fully elucidated, especially in the juvenile, developing brain. Here we characterized lithium distribution in the juvenile mouse brain during 28 days of continuous treatment that result in clinically relevant serum concentrations. By using Time-of-Flight Secondary Ion Mass Spectrometry- (ToF-SIMS) based imaging we were able to delineate temporospatial lithium profile throughout the brain and concurrent distribution of endogenous lipids with high chemical specificity and spatial resolution. We found that Li accumulated in neurogenic regions and investigated the effects on hippocampal neurogenesis. Lithium increased proliferation, as judged by Ki67-immunoreactivity, but did not alter the number of doublecortin-positive neuroblasts at the end of the treatment period. Moreover, ToF-SIMS revealed a steady depletion of sphingomyelin in white matter regions during 28d Li-treatment, particularly in the olfactory bulb. In contrast, cortical levels of cholesterol and choline increased over time in Li-treated mice. This is the first study describing ToF-SIMS imaging for probing the brain-wide accumulation of supplemented Li in situ. The findings demonstrate that this technique is a powerful approach for investigating the distribution and effects of neuroprotective agents in the brain.


Asunto(s)
Encéfalo/metabolismo , Litio/metabolismo , Imagen Molecular , Neurogénesis , Animales , Barrera Hematoencefálica/metabolismo , Peso Corporal , Giro Dentado/metabolismo , Femenino , Hipocampo/metabolismo , Inmunohistoquímica , Cinética , Metabolismo de los Lípidos , Litio/sangre , Ratones , Imagen Molecular/métodos , Neuronas/metabolismo
19.
Lipids Health Dis ; 15: 71, 2016 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-27048382

RESUMEN

BACKGROUND: Long-chain polyunsaturated fatty acids (PUFAs) are major components of the phospholipids that forming the cell membrane. Insufficient availability of PUFAs during prenatal period decreases accretion of docosahexaenoic acid (DHA) in the developing brain. DHA deficiency is associated with impaired attention and cognition, and would precipitate psychiatric symptoms. However, clinical studies on the potential benefits of dietary DHA supplementation to neural development have yielded conflicting results. METHODS: To further investigate the neurochemical influence of maternal PUFAs levels, we assessed the functioning of various neurotransmitter systems including glutamatergic, dopaminergic, norepinephrinergic and serotoninergic systems in the brain of neonatal female rats by HPLC-MS/MS. Meanwhile, the cell proliferation of neonatal rats was investigated using immunefluorescence. RESULTS: Different maternal n-3 PUFAs dietary influenced the FA composition, cell proliferation in the dentate gyrus of hippocampus and the contents of γ-aminobutyric acid (GABA), glutamine (GLN), dopamine (DA) and its metabolites [3,4- dihydroxyphenyl acetic acid (DOPAC) and homovanillic acid (HVA)], norepinephrine (NE), vanilmandelic acid (VMA) and 5-HT turnover in the brain of neonatal rats. However, the mRNA expression of key synthase of neurotransmitters remains stable. CONCLUSIONS: Our study showed that maternal deficiency of n-3 PUFAs might play an important role in central nervous system of neonatal female rats mainly through impairing the normal neurogenesis and influencing glutamatergic system and 5-HT turnover.


Asunto(s)
Giro Dentado/citología , Giro Dentado/metabolismo , Ácidos Grasos Insaturados/farmacología , Fenómenos Fisiologicos Nutricionales Maternos , Animales , Animales Recién Nacidos , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Encéfalo/fisiología , Proliferación Celular/efectos de los fármacos , Giro Dentado/efectos de los fármacos , Dieta , Ácidos Grasos/metabolismo , Ácidos Grasos Insaturados/deficiencia , Femenino , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Ácido Glutámico/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Neurotransmisores/metabolismo , Embarazo , Ratas Sprague-Dawley , Serotonina/metabolismo
20.
Sci Rep ; 6: 18744, 2016 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-26795072

RESUMEN

The phenomenal finding that listening to Mozart K.448 enhances performance on spatial tasks has motivated a continuous surge in promoting music education over the past two decades. But there have been inconsistent reports in previous studies of the Mozart effect. Here conducted was a systematic study, with Mozart and retrograde Mozart music, Mozart music rhythm and pitch, behaviours and neurobiology tests, rats and humans subjects. We show that while the Mozart K.448 has positive cognitive effects, the retrograde version has a negative effect on rats' performance in the Morris water maze test and on human subjects' performance in the paper folding and cutting test and the pencil-and-paper maze test. Such findings are further confirmed by subsequent immunohistochemical analyses in rats on the neurogenesis and protein levels of BDNF and its receptor, TrkB. Furthermore, when the rhythm and pitch of the normal and retrograde Mozart music are manipulated independently, the learning performance of the rats in the Morris water maze test indicated that rhythm is a crucial element in producing the behavioural effects. These findings suggest that the nature of Mozart effect is the Mozart rhythm effect, and indicate that different music may have quite different to opposite effects. Further study on rhythm effect may provide clues to understand the common basis over animals from rats to humans.


Asunto(s)
Conducta , Música , Neurobiología , Neuronas/fisiología , Canto , Estimulación Acústica , Adolescente , Animales , Corteza Auditiva/metabolismo , Conducta Animal , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Cognición , Giro Dentado/metabolismo , Femenino , Humanos , Masculino , Aprendizaje por Laberinto , Neurogénesis , Lóbulo Parietal/metabolismo , Discriminación de la Altura Tonal , Ratas Sprague-Dawley , Receptor trkB/metabolismo , Percepción Espacial , Análisis y Desempeño de Tareas , Agua , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA